Open original FDA record ↗Recall record
- FDA identifier
- Z-1014-2023
- Company in FDA record
- CooperVision, Inc.
- FDA classification date
- Jan 24, 2023
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Lenses may be of the incorrect power. A patient who uses an affected lens may experience poor visual acuity.
Source facts
- Action
- On December 27, 2022, the firm notified affected wholesale/distributor and Eye Care Practitioner consignees via Urgent Medical Device Correction letters. Customers were instructed to stop any further distribution of product from affected lot numbers and dispose of any affected product still in inventory. Customers may also return product. Customers who are affected by this recall are eligible for credit or replacement. Distributors and Eye Care Practitioners should also contact downstream Eye Care Practitioner customers as well as patients who have received product from the affected lots. Patients with questions may contact CooperVision's Customer Service team at 800-341-2020, 9:00 AM 7:00 PM ET, Monday Friday, or they can visit CooperVision s website at coopervision.com/our-company/contact-us/complaint.
- Initiated
- 2022-12-27
- Root cause
- Process control
- Distribution
- Distribution to US states of CA, FL, IA, KY, NC, NY, OH, OR, WI; Canada and Japan.
- Recall number
- Z-1014-2023
- Recall status
- Open, Classified
- CDRH record ID
- 197604
- FDA classified
- 2023-01-24
- Recall event number
- 91389